<description>&lt;p&gt;Interview with Urs Fischer, MD, MSc, author of Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD.&lt;br /&gt; &lt;br /&gt; &lt;strong&gt;Related Content:&lt;/strong&gt;&lt;/p&gt; &lt;ul&gt; &lt;li&gt;&lt;a class="related-article" href= "https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2024.1450?utm_source=podcast_platforms&amp;utm_medium=referral&amp;utm_campaign=related_article_links" target="_blank" rel="noopener"&gt;Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation&lt;/a&gt;&lt;/li&gt; &lt;/ul&gt;</description>

JAMA Neurology Author Interviews

JAMA Network

Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation

MAY 28, 202418 MIN
JAMA Neurology Author Interviews

Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation

MAY 28, 202418 MIN

Description

Interview with Urs Fischer, MD, MSc, author of Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. Related Content: